During the follow-up period, none of the patients died, and 3.5% were referred for conventional angiography for recurrent or worsening chest pain.
随访期间,没有病人死亡,3.5%的患者因再出现或加重胸痛而接受传统造影术。
2
Makhija said the new combination added weeks to the standard survival period for recurrent patients, and the drug combo was well-tolerated by the body and caused minimal side effects.